Maca R D
Cancer Res. 1976 Apr;36(4):1218-21.
With a newly developed turbidometric method, concanavalin A was shown to agglutinate normal lymphocytes, lymphoma cells, and leukemic cells from chronic lymphocytic leukemia and from acute myelocytic and lymphocytic leukemia. However, there was a marked difference in the kinetics of this agglutination process. Leukemic blast cells and cells from a patient with convoluted lymphoma agglutinated poorly in this system. Conversely, the degree of agglutination for chronic lymphocytic leukemia cells was greater than that for the blast cells and also slightly greater than that for normal lymphocytes. Cultured cells from a Burkitt's lymphoma (Raji) and from a patient with poorly differentiated lymphoma agglutinated very rapidly with concanavalin A. Prior incubation of all cell types with neuraminidase markedly enhanced the agglutination process similar to that of trypsinization. Thus, these studies illustrate the usefulness of this method in quantitating the kinetics of agglutination of various human neoplastic cell types by concanavalin A.
通过一种新开发的比浊法,已表明伴刀豆球蛋白A能凝集正常淋巴细胞、淋巴瘤细胞以及来自慢性淋巴细胞白血病、急性髓细胞性白血病和急性淋巴细胞白血病的白血病细胞。然而,在这种凝集过程的动力学方面存在显著差异。白血病原始细胞以及来自一名脑回状淋巴瘤患者的细胞在该系统中凝集较差。相反,慢性淋巴细胞白血病细胞的凝集程度大于原始细胞,也略大于正常淋巴细胞。来自伯基特淋巴瘤(拉吉细胞系)和一名低分化淋巴瘤患者的培养细胞与伴刀豆球蛋白A的凝集非常迅速。所有细胞类型先用神经氨酸酶预孵育可显著增强凝集过程,类似于胰蛋白酶处理后的情况。因此,这些研究说明了该方法在定量伴刀豆球蛋白A对各种人类肿瘤细胞类型的凝集动力学方面的实用性。